Alstom shares sink 28% after outlook cut on Coradia Max execution issues

Alstom shares fell more than 28% in early trading after it cut fiscal 2026/27 adjusted EBIT margin guidance to around 1% from around 6.5% and shifted its free-cash-flow outlook from positive to negative €1.5 billion. First-half sales rose 3% year over year to €9.3 billion, but adjusted EBIT margin dropped to around -4% from 6.4%, amid project execution and industrialization issues, particularly with the Coradia Max platform. First-half free cash flow was negative €1.25 billion, and net debt rose to €1.1 billion at September 30, 2026, from €0.4 billion at March 31.

Analysis

The key issue is not the revised earnings number alone; it is whether project-level cost and delivery assumptions are still reliable. Germany-linked execution problems can trigger a second-order cycle of rework, customer remedies, delayed acceptance and slower cash collection. That would make the order book less valuable as a near-term cash-flow indicator even if book-to-bill remains above one. Competitors such as Siemens Mobility, Stadler and CAF could benefit at future tenders, but certification and fleet-planning cycles make rapid share transfer unlikely. Suppliers and subcontractors exposed to affected projects may instead face delayed payments or tougher cost negotiations.

The immediate share-price shock may already reflect a large part of the guidance reset; without valuation and balance-sheet funding detail, chasing the decline is not attractive. Over 1–3 months, focus on a credible cash-flow bridge, project provisions and evidence that production/homologation is resuming. Over 6–18 months, the structural question is whether Alstom can price execution risk more conservatively without sacrificing order intake. Management’s normalization language is not proof of recovery. The deleveraging objective also needs a specified funding path; otherwise negative cash generation raises refinancing or asset-sale risk. Falsifiers: sustained improvement in delivery/acceptance and project margins, a cash-flow outlook restored without balance-sheet actions, or conversely further guidance cuts and rising net debt.

Key Decisions for Investors

• Keep ALO underweight; do not add solely because of the one-day dislocation. A tactical short is more attractive on a relief rally than after the gap down, preferably versus a diversified European industrials basket to limit market beta. No price target is supportable from the supplied data.
• Set a 1–3 month diligence trigger around the next update: seek project-level margin/provision disclosures, production and homologation progress, customer acceptance, and a quarterly cash bridge. Without these, treat the stated recovery path as unverified.
• Avoid assuming order growth converts to cash. Track net debt and working capital; any further deterioration or a credible need for asset sales/equity financing would strengthen the downside case. A clear financing plan alongside improving cash conversion would invalidate it.
• Watch future rail tenders for evidence of competitor substitution, but do not yet trade a near-term winner: qualification and procurement timelines constrain immediate revenue capture.